David Schaaf
Directeur Technique/Scientifique/R&D chez PDS BIOTECHNOLOGY CORPORATION
Postes actifs de David Schaaf
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| PDS BIOTECHNOLOGY CORPORATION | Directeur Technique/Scientifique/R&D | 01/09/2022 | - |
Historique de carrière de David Schaaf
Anciens postes connus de David Schaaf
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ZOGENIX, INC. | Directeur Technique/Scientifique/R&D | - | - |
Formation de David Schaaf
| The Trustees of Columbia University in The City of New York | Graduate Degree |
| Stanford University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 2 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PDS BIOTECHNOLOGY CORPORATION | Health Technology |
| Entreprise privées | 1 |
|---|---|
Zogenix, Inc.
 Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Zogenix, Inc. is a pharmaceutical company. The firm engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include Fintepla and MT1621. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA. | Health Technology |
- Bourse
- Insiders
- David Schaaf
- Expérience